Coronary Arteriosclerosis Clinical Trial
Official title:
Phase 3 Study of Poly Unsaturated Fatty Acids of Omega 3 as an Anti Platelet Agent on Biomarkers of Cardiac Necrosis Including CKMB and Troponin I and Inflammation Marker CRP
Verified date | December 2012 |
Source | hahid Beheshti University of Medical Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | Iran: Ethics Committee |
Study type | Interventional |
The purpose of this study is to investigate the effect of omega 3 on biomarkers of cardiac necrosis(CKMB and troponin I) and inflammation marker CRP.
Status | Completed |
Enrollment | 104 |
Est. completion date | May 2012 |
Est. primary completion date | May 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - candidate of elective PCI - treatment with aspirin at least 5 days before PCI Exclusion Criteria: - high CKMB and troponin I level - cardiac bypass in recent 3 months - platelet count < 70×10 9/L - sever chronic renal failure - active bleeding - treatment with glycoprotein IIb/IIIa inhibitors during PCI - treatment with bivalirudin during PCI - sensitivity to aspirin and clopidogrel |
Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Iran, Islamic Republic of | Moddaress Hospital | Tehran |
Lead Sponsor | Collaborator |
---|---|
hahid Beheshti University of Medical Sciences |
Iran, Islamic Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cardiac Necrosis Biomarkers (CKMB, Troponin I) | difference between study and control group in 8 and 24 hrs after percutaneous coronary intervention | 8 and 24 hrs after percutaneous coronary intervention | No |
Primary | Inflammation Marker (CRP) | difference between study and control group in 8 and 24 hrs after percutaneous coronary intervention | 8 and 24 hrs after percutaneous coronary intervention | No |
Secondary | MACE(Major Adverse Cardiac Effect) Defined as Need for Target Revascularization, Myocardial Infarction and Death | 30 days | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00069654 -
Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease
|
Phase 2 | |
Completed |
NCT02919124 -
Epicardial Echocardiography of Coronary Anastomoses Using the Echoclip Device
|
N/A | |
Recruiting |
NCT02639962 -
Characteristics of Culprit Lesion and Changes in Plaque Composition. A Dual Energy Cardiac CT Study
|
N/A | |
Completed |
NCT02494557 -
Risk Stratification for Coronary Artery Disease With Type 2 Diabetic Patients
|
N/A | |
Recruiting |
NCT01466452 -
Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve Surgery
|
Phase 2 | |
Completed |
NCT01182428 -
XIENCE V: SPIRIT WOMEN Sub-study
|
Phase 4 | |
Completed |
NCT00371891 -
Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS)
|
Phase 4 | |
Completed |
NCT00368953 -
YUKON Choice Versus TAXUS Liberté in Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT00319449 -
Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)
|
Phase 4 | |
Completed |
NCT00091754 -
Atherosclerosis, Plaque and CVD in Communities
|
||
Completed |
NCT00069797 -
Epidemiology of Coronary Heart Disease in Men Aged 40 and Over
|
N/A | |
Completed |
NCT00024596 -
Family Heart Study - Subclinical Atherosclerosis Network (FHS-SCAN)
|
N/A | |
Completed |
NCT00037245 -
Androgens and Subclinical Atherosclerosis in Young Women - Ancillary to CARDIA
|
N/A | |
Withdrawn |
NCT00006497 -
Long-Term Effects of Subclinical CAD on Cardiac Function
|
||
Completed |
NCT00006502 -
Myocardial Perfusion, Risk Factors, and Coronary Calcium
|
N/A | |
Completed |
NCT00006407 -
Sex Steroid Hormones and Risk of CHD in Women
|
N/A | |
Completed |
NCT00006309 -
Pooling of Cohort Studies on Diet & Coronary Disease
|
N/A | |
Completed |
NCT00005269 -
Family Blood Pressure Program - GENOA
|
||
Completed |
NCT00000508 -
Stanford Coronary Risk Intervention Project (SCRIP)
|
Phase 3 | |
Completed |
NCT00005147 -
Epidemiology of Atherosclerosis
|
N/A |